Boothbay Fund Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-21,582
| Closed | -$322K | – | 1893 |
|
|
2023
Q3 | $322K | Buy |
+21,582
| New | +$322K | 0.01% | 1043 |
|
|
2023
Q2 | – | Sell |
-16,249
| Closed | -$142K | – | 2189 |
|
|
2023
Q1 | $142K | Sell |
16,249
-1,822
| -10% | -$15.9K | ﹤0.01% | 1595 |
|
|
2022
Q4 | $113K | Buy |
+18,071
| New | +$113K | ﹤0.01% | 1512 |
|
|
2022
Q3 | – | Sell |
-14,479
| Closed | -$43K | – | 2402 |
|
|
2022
Q2 | $43K | Buy |
+14,479
| New | +$43K | ﹤0.01% | 1819 |
|
|
2020
Q3 | – | Sell |
-159,465
| Closed | -$557K | – | 1169 |
|
|
2020
Q2 | $557K | Sell |
159,465
-54,971
| -26% | -$192K | 0.04% | 460 |
|
|
2020
Q1 | $317K | Buy |
+214,436
| New | +$317K | 0.03% | 473 |
|
|
2019
Q4 | – | Sell |
-26,790
| Closed | -$137K | – | 951 |
|
|
2019
Q3 | $137K | Buy |
+26,790
| New | +$137K | 0.01% | 588 |
|
|
2017
Q4 | – | Sell |
-50,077
| Closed | -$404K | – | 769 |
|
|
2017
Q3 | $404K | Buy |
+50,077
| New | +$404K | 0.07% | 244 |
|
|
2015
Q4 | – | Sell |
-21,897
| Closed | -$42K | – | 652 |
|
|
2015
Q3 | $42K | Buy |
+21,897
| New | +$42K | 0.02% | 412 |
|